Management

CEO and Chairman – Peter Katevatis
Peter Katevatis Esq. Co-Founder of Mediscience with Dr. Robert Alfano has served as Chairman of the Board of Directors / legal counsel since 1993. Admitted to the PA. NY, NJ and DC bar associations. Mr. Katevatis was a trustee of the New Jersey State's Police and Fireman Retirement Pension Fund 1990-98 and served as a member of the State of New Jersey Investment Council from 1990 until December, 1992. He serves as a judicial arbitrator for the American Arbitration Association and the National Association of Securities Dealers (NASD). Mr. Katevatis is also a long-time member of the National District Attorney's Association and a member of the New York Academy of Science.

CFO– Frank D. Benick, CPA
Proven track record of management and supervision of an accounting staff of 50+. Experience as a Chief Financial Officer with a specific expertise in all phases of corporate accounting re: public/private companies including filing of Forms 10-Q, 10-K, financial statements, internal controls and budgets. Mr. Benick is presently a CPA and partner at Cust, Dori & Benick. Mr. Benick was previously employed as a CPA with J.H. Cohn & Co. and a Senior Accountant at Amper Politziner & Mattia.

Chief Medical Operating Officer Stephene Lubicz, M.D.
Chief Medical Operating Officer Dr. Stephane Lubicz consultant with Mediscience on the clinical aspects of the CD Ratiometer project. -- has over 20 years of business and private practice experience in gynecology oncology. Responsible for coordinating the management of the clinical development of the Company's platform projects with focus on implementing clinical study protocols, including those for projects in the U.S as well as Mexico and South/Central America. He received his Bachelor of Science Degree, Cum Laude from Free University, Brussels, Belgium and his M.D. degree fromt Free University as well. In addition to his active role as a practicing New York City physician, specializing in Gynecologic Oncology, his professional experience covers a broad range of activities in the Research and Development of pharmaceutical products. Specifically, this includes United States consultant to B & A Inc., a company that operates as a service group for coordinating and organizing clinical trials (Phase I, II, III) in Mexico and throughout Latin America . As Medical Director, Clinical Development Oncology for Daiichi Pharmaceutical Corp. he was responsible for coordinating and the management of the clinical development of the Company's drug projects with focus on implementing clinical study protocols, including those for projects in the U.S as well as Mexico and South/Central America. He has been an active participant in the working as a consultant with Mediscience on the clinical aspects of the CD Ratiometer project.

Regulatory Affairs– Dr. Robert Schiff / Schiff & Companff
Founded 1982, Schiff & Company is an international Regulatory Affairs and Clinical Research Organization. Senior Management personnel each have more than 25 years experience in the health care and regulatory fieldsfor drugs, biologics, diagnostics, and devices. Schiff & Company represents both domestic and international organizations to the FDA and to foreign regulatory bodies and writes all appropriate regulatory filings.

Mediscience Audit Committee
John Kennedy has been chairman of the AuditCommittee since 2000 and Vice President Secretary and director of the Company since 1982. Mr. Kennedy is Chairman of the Board and CEO of Pepco Manufacturing Co., a 30 yr fabricator for the electronics industry located in Somerdale, New Jersey. Mr. Kennedy served as director and member of the Audit Committee of First Peoples Bank of New Jersey and as a member of its executive board until 1994 when First Peoples Bank was acquired by Corestates Bank .

Schiff & Company

Clinical Research and Regulatory Affairs

• Schiff & Company, founded in 1982, is an international Regulatory Affairs and Clinical Research Organization. Senior Management personnel each have more than 25 years experience in the health care and FDA regulatory fields.

• Schiff & Company will conduct and monitor clinical studies for Mediscience diagnostic devices. Schiff represent both domestic and international organizations to the FDA and to foreign regulatory bodies. Will write all appropriate regulatory filings.

• Schiff staff plans regulatory strategy, prepares clinical development plans, performs GMP and validation audits, writes SOP’s and conducts due diligence.